A recent study by Li et al. did not reveal any significant differences in PD1 and PD-L1 expression between MSI-H and MSS CRC patients, but reported that a higher expression of TIL PD1 and tumor PD-L1 was associated with better prognosis, especially in patients with MMR-proficient disease [45]. This evidence concerns the gene CD274 and colorectal carcinoma.